Mobile

A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers

Update Il y a 4 ans
Reference: NCT01499004

Woman and Man

  • | Country :
  • Singapore
  • | organs :
    • -
  • | Specialty :
    • -

Extract

This study will explore the drug behavior and safety following a single dose of three different 22 milligram tofacitinib (CP-690,550) modified-release formulations in 30 healthy volunteers. These formulations will be compared to 10 milligram tofacitinib (CP-690-550) in an immediate-release formulation.

Inclusion criteria

  • Healthy

Links